Quoin Pharmaceuticals Ltd - ADR represents shares of Quoin Pharmaceuticals, a specialty pharmaceutical company, in the United States market. The company primarily focuses on developing products for rare and orphan diseases, aiming to address significant unmet medical needs. As an American Depository Receipt (ADR), Quoin Pharmaceuticals Ltd - ADR allows U.S. investors easier access to the company's international shares, providing a bridge between domestic investors and foreign equities. Operating within the pharmaceutical industry, the company is engaged in innovative research and development to bring new therapies to market, thus significantly impacting the healthcare sector, particularly in the niche area of rare disease management. By offering a platform for investors in the U.S. to participate in global healthcare advancements, Quoin Pharmaceuticals Ltd - ADR plays a crucial role in diversifying investment portfolios and supporting the development of essential pharmaceutical solutions.